Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Apposite Capital promotes Sam Gray to partner

London, UK – 11 July 2011. Apposite Capital, the healthcare specialist investment firm, today announces the promotion of Sam Gray to Partner. Sam together with Steve Adkin manages the firm’s healthcare services investments in the UK. Apposite’s healthcare services investments focus on backing differentiated and innovative business models that bring high quality care provision and global best practice to the UK.

Sam Gray joined Apposite in 2007. He started his career covering healthcare at Deutsche Bank investment banking in their M&A practice. He then joined UCB Pharmaceuticals where he was involved in a number of global and regional in-licensing and M&A transactions, including the UCB’s strategic acquisition of Celltech, the UK public biotech company, in 2004. Sam Gray holds an MBA from Harvard Business School and an MSci in Natural Sciences from Cambridge University, UK.

Commenting on today’s announcement, David Porter, Managing Partner of Apposite Capital, said: “We are delighted to continue broadening the Partnership. Sam is actively involved in all aspects of our healthcare services investment strategy and plays a key role helping our healthcare services portfolio companies develop and implement their growth strategy on a day to day basis. Apposite has a hands on investment management approach which focuses on rapidly growing small UK revenue generating healthcare services businesses into national champions, as well as building businesses to specifically address unmet areas of needs where existing healthcare or medical provision is poor or lacking in the UK.”


Attachment: Photograph of Sam Gray, Partner, Apposite Capital

Media contact:

Valerie Auffray

Tel: +44(0) 20 7090 6383


About Apposite Capital

Apposite Capital is an independent investment firm focused exclusively on Healthcare. The firm makes primary and secondary investments in private companies involved in Healthcare Services and Life Sciences.

Apposite balances its investments across all stages of company development, providing buyout and growth capital as well as venture financings. The firm is committed to adding value to its portfolio companies and typically has an active representation at the Board of Directors.

Apposite has an in-depth sector knowledge covering all aspects of the healthcare industry globally, with a unique unrivalled reach to Japan. The investment team combines complementary entrepreneurial, private equity and investment banking skills.

Created in 2006, Apposite is headquartered in London, UK and has a presence in San Francisco, CA, USA.

Valerie Auffray

Investor Relations Manager

Apposite Capital

Bracken House

One Friday street

London EC4M 9JA

Direct tel: +44 (0) 20 7090 6383


Publisher Contact Information:

Apposite Capital
+44 (0) 20 7090 6383

Company profile of Apposite Capital
Past press releases of Apposite Capital.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Aug 19€7.0MAgriculture related
Aug 19€9.0MInternet commerce
Aug 19€10.0ME-Commerce
Aug 19€63.0MBusiness applications
Aug 16€16.0ME-Commerce
Aug 16€6.0MBusiness applications
Aug 16N/ASoftware development

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.